← Leaderboards
Hitesh Deshmukh
Cincinnati Childrens Hosp Med Ctr
$5,539,046
Attributed
$5,539,046
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $915.9K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,539,046 · 4
By mechanism
R01$4,037,308 · 2
R35$915,924 · 1
K08$585,814 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- H Leighton Grimes$23,205,568
- Tanya Kalin$7,313,192
- Jose A. Cancelas$9,659,208
- Theodosia Anastasios Kalfa$3,388,770
- Jennifer Michelle Davis$10,964,584
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsHomeostasisInfantCellsImmunePostnatalLymphoid CellSignal TransductionInterruptionLungProgramsNeonatalResistanceBacterial PneumoniaCommensal MicrobesCommensal BacteriaPneumoniaMucous MembraneNewborn InfantFitnessPatternIntestinesIn VivoAntibodies
Grant awards (15)
Establishing lifelong trajectories of pulmonary health$643,515
R35 · FY2025 · HL · contact PI
Establishing lifelong trajectories of pulmonary health$272,409
R35 · FY2025 · HL · contact PI
Tissue niches for ILC3 development in newborn's lung$479,921
R01 · FY2024 · HL · contact PI
Tissue niches for ILC3 development in newborn's lung$489,715
R01 · FY2023 · HL · contact PI
Tissue niches for ILC3 development in newborn's lung$489,715
R01 · FY2022 · HL · contact PI
Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria$417,648
R01 · FY2022 · HL · contact PI
Tissue niches for ILC3 development in newborn's lung$489,715
R01 · FY2021 · HL · contact PI
Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria$417,648
R01 · FY2021 · HL · contact PI
Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria$417,648
R01 · FY2020 · HL · contact PI
Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria$417,649
R01 · FY2019 · HL · contact PI
Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria$417,649
R01 · FY2018 · HL · contact PI
Role of commensal bacteria in regulating neutrophil-mediated host defense in neonates$163,037
K08 · FY2018 · HD · contact PI
Role of commensal bacteria in regulating neutrophil-mediated host defense in neonates$163,037
K08 · FY2017 · HD · contact PI
Role of commensal bacteria in regulating neutrophil-mediated host defense in neonates$129,870
K08 · FY2016 · HD · contact PI
Role of commensal bacteria in regulating neutrophil-mediated host defense in neonates$129,870
K08 · FY2015 · HD · contact PI